Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer
Authors:
Open Access
- 6 October 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (61) , 103543-103556
Abstract
Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancerKeywords
This publication has 46 references indexed in Scilit:
- Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?Cancers, 2013
- Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatmentProceedings of the National Academy of Sciences, 2012
- Redox signaling loops in the unfolded protein responseCellular Signalling, 2012
- The human protein disulfide isomerase gene familyHuman Genomics, 2012
- Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: Protein disulfide‐isomerase A6 and apolipoprotein A‐IJournal of Gastroenterology and Hepatology, 2011
- The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated With Differentiation and Survival in Ovarian CancerAmerican Journal of Surgical Pathology, 2011
- Nitrosative Stress–Induced S-Glutathionylation of Protein Disulfide Isomerase Leads to Activation of the Unfolded Protein ResponseCancer Research, 2009
- Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum StressCancer Research, 2008
- ER chaperones in mammalian development and human diseasesFEBS Letters, 2007
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998